Skip to main content
Clinical Trials/NCT03297164
NCT03297164
Completed
Not Applicable

One Year Incidence Rate of Heart Failure After Acute Myocardial Infarction With Optimal Treatment-A Prospective,Multicenter,Cohort Study

Harbin Medical University19 sites in 1 country12,043 target enrollmentDecember 21, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Myocardial Infarction
Sponsor
Harbin Medical University
Enrollment
12043
Locations
19
Primary Endpoint
incidence rate of heart failure
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The main purpose of this study is to build a multi-center, prospective and regionally representative acute myocardial infarction(AMI) cohort,and build a study platform for heart failure caused by AMI; To explore the 1 year incidence rate of heart failure after AMI given the optimized treatment and the treatment model affecting the incidence rate of heart failure, and finally to reduce the incidence rate of heart failure by 5%.

Detailed Description

the study aim to enroll 12000 acute myocardial infartion (AMI) patients, including ST-segment elevation myocardial infarction (STEMI) and non ST-segment elevation myocardial infarction (NSETMI), Patients were divided into two groups(optimized group and un-optimized group) according to treatment models they accepted in 20 reginally representative hosptials of China. whether optimizaed or not is judged by 4 four aspects,including emergency treatment procedure, pre-infusion medication, reperfusion strategy selection, and early rehabilitation after reperfusion.Patients were followed at 1 month, 6 months and 12 months. The physical condition and clinical events(heart failure, death, re-infarction, revascularization, apoplexy, malignant arrhythmias, bleeding events, other adverse events)were collected at follow up.

Registry
clinicaltrials.gov
Start Date
December 21, 2017
End Date
June 30, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Harbin Medical University
Responsible Party
Principal Investigator
Principal Investigator

Yu Bo

director

Harbin Medical University

Eligibility Criteria

Inclusion Criteria

  • age≥18 years
  • diagnosed acute myocardial infarction
  • signed the informed consent form

Exclusion Criteria

  • AMI is caused by surgery, trauma, gastrointestinal bleeding or complications of PCI;
  • AMI occurred in patients who have been hospitalized for other reasons;
  • patients with previous history of chronic heart failure;
  • researchers judging that patient's compliance was poor and could not complete the study according to the requirements.
  • life expectancy is less than 12 months;
  • heart transplant patients;
  • patients with tumors;

Outcomes

Primary Outcomes

incidence rate of heart failure

Time Frame: 12th month after diacharge

incidence rate of heart failure of acute myocardial infarction at 12th month

Secondary Outcomes

  • MACCE rate(12th month after diacharge)
  • bleeding rate(12th month after diacharge)
  • severe adverse drug reactions(12th month after diacharge)

Study Sites (19)

Loading locations...

Similar Trials